UBE2J1 and colorectal carcinoma: In this study, we first reported that UBE2J1, a ubiquitin-conjugating enzyme, inhibited CRC cell proliferation and metastasis in an RPS3-dependent manner, indicating that UBE2J1 may serve as a tumor suppressor protein that constrains CRC development and progression.